Preoperative chemoradiotherapy is widely used to improve local control of disease, sphincter preservation and to improve survival in patients with locally advanced rectal cancer. Patients enrolled in the present study underwent preoperative chemoradiotherapy, followed by surgical excision. Response to chemoradiotherapy was evaluated according to Mandard’s Tumor Regression Grade (TRG). TRG 3, 4 and 5 were considered as partial or no response while TRG 1 and 2 as complete response. From pretherapeutic biopsies of 84 locally advanced rectal carcinomas available for the analysis, only 42 of them showed 70% cancer cellularity at least. By determining gene expression profiles, responders and non-responders showed significantly different expression levels for 19 genes (P < 0.001). We fitted a logistic model selected with a stepwise procedure optimizing the Akaike Information Criterion (AIC) and then validated by means of leave one out cross validation (LOOCV, accuracy D 95%). Four genes were retained in the achieved model: ZNF160, XRCC3, HFM1 and ASXL2. Real time PCR confirmed that XRCC3 is overexpressed in responders group and HFM1 and ASXL2 showed a positive trend. In vitro test on colon cancer resistant/susceptible to chemoradioterapy cells, finally prove that XRCC3 deregulation is extensively involved in the chemoresistance mechanisms. Protein-protein interactions (PPI) analysis involving the predictive classifier revealed a network of 45 interacting nodes (proteins) with TRAF6 gene playing a keystone role in the network. The present study confirmed the possibility that gene expression profiling combined with integrative computational biology is useful to predict complete responses to preoperative chemoradiotherapy in patients with advanced rectal cancer.

Agostini, M., Zangrando, A., Pastrello, C., D'Angelo, E., Romano, G., Giovannoni, R., et al. (2015). A functional biological network centered on XRCC3: A new possible marker of chemoradiotherapy resistance in rectal cancer patients. CANCER BIOLOGY & THERAPY, 16(8), 1160-1171 [10.1080/15384047.2015.1046652].

A functional biological network centered on XRCC3: A new possible marker of chemoradiotherapy resistance in rectal cancer patients

ROMANO, GABRIELE;GIOVANNONI, ROBERTO;LAVITRANO, MARIALUISA;
2015

Abstract

Preoperative chemoradiotherapy is widely used to improve local control of disease, sphincter preservation and to improve survival in patients with locally advanced rectal cancer. Patients enrolled in the present study underwent preoperative chemoradiotherapy, followed by surgical excision. Response to chemoradiotherapy was evaluated according to Mandard’s Tumor Regression Grade (TRG). TRG 3, 4 and 5 were considered as partial or no response while TRG 1 and 2 as complete response. From pretherapeutic biopsies of 84 locally advanced rectal carcinomas available for the analysis, only 42 of them showed 70% cancer cellularity at least. By determining gene expression profiles, responders and non-responders showed significantly different expression levels for 19 genes (P < 0.001). We fitted a logistic model selected with a stepwise procedure optimizing the Akaike Information Criterion (AIC) and then validated by means of leave one out cross validation (LOOCV, accuracy D 95%). Four genes were retained in the achieved model: ZNF160, XRCC3, HFM1 and ASXL2. Real time PCR confirmed that XRCC3 is overexpressed in responders group and HFM1 and ASXL2 showed a positive trend. In vitro test on colon cancer resistant/susceptible to chemoradioterapy cells, finally prove that XRCC3 deregulation is extensively involved in the chemoresistance mechanisms. Protein-protein interactions (PPI) analysis involving the predictive classifier revealed a network of 45 interacting nodes (proteins) with TRAF6 gene playing a keystone role in the network. The present study confirmed the possibility that gene expression profiling combined with integrative computational biology is useful to predict complete responses to preoperative chemoradiotherapy in patients with advanced rectal cancer.
Articolo in rivista - Articolo scientifico
CEA, carcinoembryonic antigen; CRT, Chemoradiotherapy; DSB, Double-strand breaks; Gy, Gray; HT, High throughput; PPI, Protein-protein interaction; RC, Rectal cancer; RIN, RNA integrity number; SNP, Single nucleotide polymorphism; SSB, Single-strand breaks; XRCC3; biological network; integrated approach; mRNA, mRNA; microarray; pCRT, Preoperative chemoradiotherapy; preoperative chemoradiotherapy; rectal cancer; siRNA, Small interfering RNA; treatment response
English
2015
16
8
1160
1171
partially_open
Agostini, M., Zangrando, A., Pastrello, C., D'Angelo, E., Romano, G., Giovannoni, R., et al. (2015). A functional biological network centered on XRCC3: A new possible marker of chemoradiotherapy resistance in rectal cancer patients. CANCER BIOLOGY & THERAPY, 16(8), 1160-1171 [10.1080/15384047.2015.1046652].
File in questo prodotto:
File Dimensione Formato  
Agostini M et al_CBT_2015_AUTHORS POSTPRINT.pdf

accesso aperto

Tipologia di allegato: Author’s Accepted Manuscript, AAM (Post-print)
Dimensione 2.78 MB
Formato Adobe PDF
2.78 MB Adobe PDF Visualizza/Apri
10281-88780.pdf

Solo gestori archivio

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Dimensione 1.34 MB
Formato Adobe PDF
1.34 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/88780
Citazioni
  • Scopus 42
  • ???jsp.display-item.citation.isi??? 38
Social impact